Christine Lebrun-Frenay

53PUBLICATIONS
202CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersTransport properties and non-equilibrium processesOptical technologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Aug 14, 2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

|Aug 14, 2026
Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.

|Jul 09, 2026
Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

|Jun 02, 2026
Subclinical Optic Nerve Involvement in Radiologically Isolated Syndrome: Multimodal Detection and Diagnostic Impact.

|Jun 02, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

|May 29, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Pageof 9

Frequent Collaborators

17 joint publications

Jonathan Ciron

17 joint publications

Sandra Vukusic

17 joint publications

Eric Thouvenot

15 joint publications

Elisabeth Maillart